Standard BioTools Inc. stock is up 27.46% since 30 days ago. The next earnings date is Feb 13, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 69.23% of the previous 12 November’s closed higher than October.
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems. The company also sells single cell microfluidics that comprise C1 systems; preparatory analytical instruments; and software solutions.